Deferred Tax Assets, Valuation Allowance of DNA X, Inc. from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
DNA X, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • DNA X, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $30,271,000, a 33% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

DNA X, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $30,271,000 +$7,497,000 +33% 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q4 2023 $22,774,000 -$222,000 -0.96% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q4 2022 $22,996,000 +$76,000 +0.33% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q4 2021 $22,920,000 +$8,639,000 +60% 31 Dec 2021 10-K 20 Mar 2023 2022 FY
Q4 2020 $14,281,000 +$2,467,000 +21% 31 Dec 2020 10-K/A 29 Jun 2022 2021 FY
Q4 2019 $11,814,000 +$3,726,000 +46% 31 Dec 2019 10-K/A 29 Jun 2022 2021 FY
Q4 2018 $8,088,000 +$335,000 +4.3% 31 Dec 2018 10-K 18 Mar 2021 2020 FY
Q4 2017 $7,753,000 31 Dec 2017 10-K 27 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.